Pharm Block 2 Kinetics Flashcards

1
Q

Prednisone

A

PO doses from 5-100mg QD

Metabolized in the liver to prednisolone

t 1/2 ~ 18-36 hr

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Cyclosporine

A

PO or IV for immunosuppression at 2.5-15 mg/kg QD; narrow therapeutic window

Opthalmic formulation 0.05% or 0.1% is used to increase tear production that has been suppressed by inflammation

CYP3A4 (drug interactions!); metabolites excreted in bile

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Tacrolimus

A

IV or PO; PO absorption is highly variable (needs individualized regimens)

Extensively metabolized by CYP3A4 (drug interactions!)
Metabolites excreted in bile

Concentrated in the pancreas and may INHIBIT PANCREATIC INSULIN SECRETION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Sirolimus

A

Solution or tablets for PO administration (2-5 mg QD)

Cypher is a sirolimus-eluting stent used to inhibit restenosis after stenting to treat coronary artery occlusion; 80% of sirolimus is released in 30 days and the rest in 90 days

CYP3A4 substrate (drug interactions!)
Metabolites excreted in bile

Long t 1/2 - 60 hrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Azathioprine

A

PO or IV, good oral absorption
Maintenance does is 1-3 mg/kg QD

6-MP is inactivated by oxidation (by xanthine oxidase) and methylation (by thiopurine S-methyltransferase)

Excretion is mostly renal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Mycophenolate mofetil

A

PO or IV; both routes offer essentially complete bioavailability of mycophenolic acid

Usual dose is 1g BID for kidney and liver transplants, 1.5 g BID for heart transplants

Inactive phenolic glucuronide is main metabolite; excreted almost entirely in urine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Muromonab-CD3

A

1 mg/mL solution for IV bolus administration

Usual does is 5 mg QD for 10-14 days

T cells begin to disappear from blood within minutes and reappear 1 week after therapy is halted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Basiliximab

A

Lyophilized powder that is reconstituted for IV administration

20 mg given IV as bolus injection or infusion over 20-30 min
First 20 mg dose given 2 hr prior to surgery
Second 20 mg dose is given 4 days after transplantation
Elimination half-life is 7 days; normal T cell numbers return in 7-14 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Adalimumab

A

Prefilled syringes containing 20 or 40 mg for SC injection

Maintenance dose is 40 mg Q 2 weeks

Elimination half-life is 10-20 days (mean 14 days)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Carbachol

A

0.01% solution that is instilled into anterior chamber of the eye

Miosis is maximal 2-5 min after administration

Not susceptible to AChE inactivation

Duration of miosis - 24 hrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Methacholine

A

Lyophilized powder is reconstituted in isotonic saline for inhalation via nebulizer

3-fold more resistant to AChE than acetylcholine

Most subjects return to baseline pulmonary function after 30-45 min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Bethanechol

A

PO tablets 10-50 mg TID-QID

Onset occurs 60-90 min and duration is 60 min

Not susceptible to AChE inactivation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Pilocarpine

A

0.5-6% opthalmic solution, duration 4-14 hrs
PO dose 5-10 mg TID, 3-5 hr duration

Ocusert delivers pilocarpine for 7 days via contact lens-like system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Nicotine

A

Gum, lozenge, inhaler, nasal spray, transdermal patch

Widely distributed in body tissues, especially CNS

Mostly metabolized in liver; unchanged nicotine and metabolites are excreted by kidney

t 1/2 = 30-120 min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Varenicline

A

0 .5 mg and 1 mg tablets for PO, usually 1 mg BID after 1 week ramp-up

Peak plasma concentration reached in 3-4 hr; half-life = 24 hr

Minimal metabolism, 92% is excreted unchanged in urine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Physostigmine

A

0.1% solution via IV injection or applied topically to eye

Duration of action 1-2 hr when given IV, 12-36 hr on eye

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Neostigmine

A

15 mg tablets for PO
Average dose is 10 tabs QD with individualized dosing interval

Duration of action 2-4 hr

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Edrophonium

A

IV or IM

Duration of action ranges from 5-10 min (IV) and 5-30 min (IM)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Echothiophate

A

0.03% topical opthalmic solution, 1 qtt QD-BID

Membrane penetration is poor due to high polarity

Duration of action = 100hr

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Pralidoxime

A

1-2g IV, PO, IM
Infuse in 100mL of saline given over 15-30 min with additional doses PRN

Distributes throughout extracellular water

Metabolized by liver with half-life of 74-77 min

Both unchanged drug and metabolite are excreted by kidneys

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Atropine

A

PO tabs or IV, IM or SC solution

0.5-1 mg as antisialagogue, 2-3mg for AChE inhibitor or muscarinic agonist poisoning

Well absorbed, widely distributed throughout body

Metabolized in liver
t 1/2 = 2-4 hr
Excreted renally

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Oxybutynin

A

Topically (transdermal patch) or PO (5mg BID-TID)

Widely distributed to body tissues

Onset within 30-60 min of PO, duration 6-10 hrs

CYP3A4 (enteric and hepatic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Ipratropium

A

Oral inhalation or 0.03% nasal spray
Effect lasts 4-6 hrs

Quaternary amine, doesn’t cross BBB very well

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Mecamylamine

A

PO as 2.5 mg tablets, daily dose 2.5-25mg given TID or QID

Almost completely absorbed and excreted unchanged in urine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Epinephrine

A

IV or intracardiac injection, inhalation, topically to eye

Poor PO availability; metabolized by COMT and MAO in liver and other tissues

Duration varies, generally 1-4 hrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Phenylephrine

A

Injection, PO, intranasally, opthalmically

Metabolized by MAO in liver and other tissues

Active for 30 min to 4 hr

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Clonidine

A

Epidurally, PO, transdermal patch

PO bioavailability near 100%

Highly lipid soluble, distributes widely throughout the tissues including CNS

Antihypertensive effects last up to 8hrs (PO) and up to 7 days with transdermal patch

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Isoproterenol

A

For cardiac arrests, IV infusion or IV bolus
For bronchodilation, aerosol

COMT metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Dobutamine

A

Continuous IV for

30
Q

Albuterol

A

Oral inhilation
Bronchodilation occurs within 7 min; peaks 0.5-2 hrs, lasts 2-6 hr

Liver metabolism

Excretion through urine and feces

31
Q

Salmeterol

A

Oral inhalation with BID dosing

Therapeutic effects in 14 min, peak effects 3-4 hr, effects last 12 hr

Excretion in feces

32
Q

Phentolamine

A

Lyophilized powder that is reconstituted in NS and used immediately

IV for BP control or SC as multiple injections for necrosis prevention

t 1/2 19 min

33
Q

Phenoxybenzamine

A

Oral absorption is variable, 20-30%

Distribution is extensive because of high lipophilicity and may accumulate in fatty tissues

Can last up to 7 days after discontinuation

Given days before surgery

34
Q

Prazosin

A

2-5mg TID

Antihypertensive effects peak at 2-4 hr, but complete antihypertensive effects may not occur for 4-6 weeks

Metabolized in liver by demethylation and conjugation (majority eliminated via biliary excretion in feces)

35
Q

Tamsulosin

A

Long-acting, dosing 0.4-0.8mg QD

Food decreases peak plasma concentration and bioavailability ~30%

Protein binding is 94-99% by alpha1-glycoprotein

Metabolized in liver by CYP3A4 and CYP2D6

36
Q

Yohimbine

A

PO

Bioavailability is highly variable, 7-87%

1% of unchanged drug is excreted renally

t1/2 = 36 min

37
Q

Carvedilol

A

PO, 6.25-25mg BID, take with food to reduce incidence of orthostatic hypotension

Extensively metabolized by CYP2D6 and CYP2C9

38
Q

Propranolol

A

PO or IV, highly lipophilic, widely distributed

Extensively metabolized upon first pass through liver
Metabolites excreted renally

39
Q

Timolol

A

0.25-0.5% gel-forming opthalmic solution; 1 gtt QD

Some systemic absorption

Partially metabolized by liver; metabolites and parent drug are excreted renally

40
Q

Metoprolol

A

100-450mg PO QD

Quickly absorbed but bioavailability of 0.5 because of first-pass metabolism

Moderately lipid-soluble; widely distributed

Liver CYP2D6; t1/2 = 3-4 hr

Excretion mainly thru kidney as metabolites; 5% unchanged

41
Q

Pindolol

A

5-30mg PO BID

Rapidly absorbed, little or no first pass effect

35-40% excreted unchanged in urine and 60-65% metabolized into hydroxy-metabolites (excreted as glucuronides and sulfates)

42
Q

Alpha-Methyltyrosine

A

250mg PO QID

BP decreases progressively for first 2 days of therapy; after withdrawal BP increases gradually to pretreatment values within 2-3 days

Well-absorbed and 69% is excreted in urine unchanged

43
Q

Alpha-Methyldopa

A

PO 500-2000mg QD-BID

Peak effects in 4-6 hr; duration 24 hrs

44
Q

Reserpine

A

Absorbed rapidly from GI tract following oral administration
Hypotensive effects not observed for 2-3 weeks

Widely distributed, completely metabolized in liver to inactive compounds

Antihypertensive effects can last for weeks following DC of therapy

45
Q

Botulinum Toxin A

A

IM or intradermally for local effect

Onset 2 days, duration 3-4 months

46
Q

Amphetamine

A

PO, 10-30mg OM, immediate or extended

CYPS and MAO, excreted in urine

Excretion is highly sensitive to urine pH

47
Q

Cocaine

A

Topically

Onset within 1 min, peak effect in 5 min, duration 20-60 min

48
Q

Paroxetine

A

PO, 20-50mg QD

Well-absorbed from gut, food has no effect on absorption

Metabolism in liver CYP2D6 and CYP3A4 and conjugation with glucuronic acid or sulfate, only 2% unchanged

Excretion via urine and feces

Onset 1-4 weeks

49
Q

Atomoxetine

A

PO, 0.5-1.2 mg/kg QD, increased over days or weeks

Extensive hepatic metabolism CYP2D6,

50
Q

Phenelzine

A

PO, 20-30mg TID

Well absorbed in gut

Plasma half-life is short and unrelated to duration of enzyme inhibition, which is prolonged

Onset of antidepressant action can take anywhere from 1-8 weeks

51
Q

Cyclophosphamide

A

PO or IV

Oral F= 0.87-0.96

Metabolized by CYPs, 10-20% excreted in urine unchanged

t1/2 = 3-12 hrs

52
Q

Temozolomide

A

PO or IV

Initial TX is daily for 42 days w/ concomitant focal radiotherapy
Maintenance phase is a dose for 5 days then 23 days with no drug (6 cycles)

Crosses BBB (used mainly for brain caners)

53
Q

Carboplatin

A

IV infusion over 15 min, once every 21-28 days x 6 cycles

Mostly eliminated by renal excretion within 24 hr unchanged

54
Q

Bleomycin

A

IV, IM, SC, or instilled in bladder for local TX of bladder cancer

Excreted primarily by kidneys

55
Q

Doxorubicin

A

IV as single injection Q 21-28 days

Distributes throughout body and extensively binds DNA with levels proportional to DNA content of tissue

Obesity can decrease clearance by 35%

56
Q

5-Fluorouracil

A

IV (low and inconsistent oral F)

5-FU metabolizes by dihydropyrimidine dehydrogenase in liver, mucosa, tumor cells

57
Q

Gemcitabine

A

IV over 30 min

21-28 day cycle. Doses given on days 1, 8, 15

t1/2 = 15 min

58
Q

Methotrexate

A

PO or IV

Renal excretion; glomerular filtration and active tubular secretion

59
Q

Vincristine

A

IV or weekly or longer intervals

Elimination half-life = 23-85 hrs

60
Q

Paclitaxel

A

IV (high rate of hypersensitivity rxns)

Extensive hepatic metabolism by CYP2C8, CYP3A4

70-80% dose eliminated in feces in 1 week

61
Q

Etoposide

A

IV

97% bound to serum albumin, toxicity correlates to hepatic health

56% excreted in urine, 44% excreted in feces after 5 days

62
Q

Irinotecan

A

IV infusion

Metabolized by hepatic CYPs that are induced by antiseizure drug

63
Q

Bevacizumab

A

IV

t1/2 = 20 days

64
Q

Cetuximab

A

IV

t1/2 = 7.5 days

65
Q

Rituximab

A

IV usually given 4-8 weeks

Time of onset = 50 days
Duration of response = 10-12 months

After completion of TX, can be detected in patient’s serum for 3-6 months

66
Q

Trastuzumab

A

IV for 12-18 weeks

t1/2 = 6-16 days

67
Q

Temsirolimus

A

25mg diluted and given by weekly IV

Metabolized to sirolimus by CYP3A4
Eliminated in feces

Temsirolimus t1/2 = 30 hr
Sirolimus t 1/2 = 60 hr

68
Q

Erlotinib

A

PO

Hepatic CYP3A4
Eliminated in feces

t 1/2 = 36 hr

69
Q

Imatinib

A

PO

Hepatic CYP3A4

Single dose of ketoconazole increases maximal concentration in plasma

t 1/2 imatinib and major metabolite N-desmethyl derivative = 18, 40 hrs respectively

70
Q

Sunitinib

A

PO for 4 weeks followed by 2 weeks without drug

Hepatic CYP3A4